Submit your email address to sign up for the Visionary,
or monthly newletter.

X

Search the Radiation Oncology Institute

X

Submit your email address to sign up for the Visionary,
or monthly newletter.

X

Search the Radiation Oncology Institute

X

Meet Our Researchers

  • chino_400

    Fumiko Chino, MD

    Dr. Chino and her team will prospectively quantify and investigate the effects of financial toxicity—a term for the hardship that patients face from their medical expenses—for head and neck cancer patients. The ROI is supporting Dr. Chino’s work as part of the 2018 Innovative Projects in Radiation Oncology awards, which focused on funding research to address some of the field’s most pressing challenges.
  • chino_400

    Rachel Conklin, MMS, PA-C

    Ms. Conklin and her team will explore using telehealth to increase access to their radiation oncology survivorship program for patients who receive care at a community facility, which is in a rural area approximately 50 miles from their main campus. The ROI is supporting Ms. Conklin’s work as part of the 2018 Innovative Projects in Radiation Oncology awards, which sought to address some of radiation oncology’s highest priority topics, including access to care.
  • chino_400

    Peter Greer, PhD

    Dr. Greer and his team are developing the WatchDog system that determines treatment delivery accuracy for radiation therapy patients in real-time and can prevent mistreatment. Dr. Greer received ROI’s inaugural research award to conduct the team’s first clinical demonstration of the WatchDog system as part of the ROI’s safety and quality initiative.
  • chino_400

    Karen Hoffman, MD, MHSc, MPH

    Dr. Hoffman and her team are prospectively surveying prostate cancer patients to study how receiving counseling from a radiation oncologist in a multidisciplinary clinic increases their awareness of radiation therapy as a treatment option with a favorable side effect profile and whether it changes their treatment choice. The ROI selected Dr. Hoffman’s research for a 2018 Innovative Projects in Radiation Oncology award because of its emphasis on raising the profile of radiation therapy among patients.
  • chino_400

    Geoffrey Martin, MD

    Dr. Martin and his team are running a clinical trial to that uses smartphone-connected technology to monitor lung cancer patients undergoing radiation therapy. ROI awarded Dr. Martin an Innovative Projects in Radiation Oncology grant to investigate the correlation between patient reported outcomes, the continuous biometric monitoring via smartphones and the side effects of radiation therapy.
  • chino_400

    Todd McNutt, PhD

    Dr. McNutt and his team are using big data and machine learning approaches to develop better predictive models for toxicities associated with head and neck cancer and to create a clinical decision support tool to help provide patients with more personalized care. The ROI is supporting Dr. McNutt’s groundbreaking work to stimulate this emerging field of research using big data to improve the safety and quality of radiation therapy.
  • chino_400

    Nima Nabavizadeh, MD

    Dr. Nabavizadeh and his team will prospectively study if stereotactic body radiation therapy (SBRT) can be safely used to help patients with hepatocellular carcinoma (HCC) and advanced cirrhosis as they await a liver transplant. The ROI is supporting Dr. Nabavizadeh’s work as part of the 2018 Innovative Projects in Radiation Oncology awards, which sought to address some of radiation oncology’s highest priority topics, including SBRT.
  • chino_400

    Nitin Ohri, MD

    Dr. Ohri and his team are conducting a randomized clinical trial to determine if giving patients daily customized step count goals as measured and guided through fitness trackers could improve patients’ ability to tolerate concurrent chemoradiotherapy. With an Innovative Projects in Radiation Oncology grant from ROI, Dr. Ohri is exploring whether this relatively simple intervention can reduce the number of missed treatments, decrease treatment-related toxicities and improve quality of life for cancer patients.
  • chino_400

    Malolan S. Rajagopalan, MD, MBA

    Dr. Rajagopalan developed the RadOnc Toolbox app and website that features evidence-based interventions for managing and preventing eight of the most common radiation-related toxicities and a number of other clinical tools. The ROI supported the development of the RadOnc Toolbox to provide practitioners with an evidence-based resource for toxicity management in order to improve outcomes for cancer patients and survivors.
  • chino_400

    Anand Shah, MD, MPH

    Dr. Shah and his team developed novel episode-based Medicare payment definitions for stereotactic body radiation therapy (SBRT) to treat patients with early stage non-small cell lung cancer (NSCLC). As part of ROI’s value of radiation therapy initiative, Dr. Shah’s study included an exploration of whether an academic versus nonacademic setting has an impact on the relative value of SBRT compared with surgery.
  • chino_400

    David Sher, MD, MPH

    Dr. Sher and his team conducted parallel comparative effectiveness and cost comparison studies for early-stage and locally advanced oropharyngeal cancer using two large databases, SEER-Medicare and the HealthCore Integrated Research Database (HIRD). The results from Dr. Sher’s ROI-funded study are providing important evidence about the value of radiation therapy in the treatment of oropharyngeal cancer.
  • chino_400

    Christopher Slatore, MD, MS

    Dr. Slatore and his team conducted a comparative, mixed-method study to better understand the patient-centered outcomes associated with radiation therapy versus surgery for early stage non-small cell lung cancer (NSCLC.) Dr. Slatore's ROI-funded work on the value of radiation therapy for the treatment of lung cancer laid the groundwork for additional research now being supported by the National Cancer Institute.
  • chino_400

    Chad Tang, MD

    Dr. Tang and his team will conduct an analysis to understand the barriers to access and costs associated with four treatment options for patients with prostate cancer—surgery, external beam radiation therapy, brachytherapy and active surveillance. The ROI is supporting Dr. Tang’s work as part of the 2018 Innovative Projects in Radiation Oncology awards, which focused on funding research to address some of the field’s most pressing challenges.
  • chino_400

    K. Ranh Voong, MD, MPH

    Dr. Voong received the Outstanding Article Award in the 2017 ROI Value of RT Publication Awards in partnership with Advances in Radiation Oncology. She was honored for her work as the lead author on the manuscript titled, “Long-term Economic Value of Hypofractionated Prostate Radiation: Secondary Analysis of a Randomized Trial,” and received a grant to continue her research on the value of radiation therapy.